Success Story: NIW Approved Without RFE: We Helped an Iranian Human Genetics Expert Achieve Success
Client’s Testimonial:
“I am very thankful to the team for their help with my EB-2 NIW application. They worked hard and gave me clear advice, which made the process easier. Their support was important in getting my application approved without any problems. I am happy with their service and recommend them to anyone needing help with U.S. immigration.”
On April 1st, 2025, we received another EB-2 NIW (National Interest Waiver) approval for an Expert in the Field of Human Genetics (Approval Notice).
General Field: Human Genetics
Position at the Time of Case Filing: Unemployed
Country of Origin: Iran
Country of Residence at the Time of Filing: Switzerland
Approval Notice Date: April 1st, 2025
Processing Time: 11 months, 17 days
Case Summary:
We are proud to share the successful I-140 NIW approval of a Ph.D. holder in medical genetics whose work in medical genetics and omics analysis contributes to the development of targeted strategies for managing complex diseases like obesity and cancer, conditions that continue to challenge global and U.S. healthcare systems.
The client’s proposed endeavor focuses on applying and optimizing omics data analysis to uncover the underlying mechanisms of these diseases. Her work enhances early diagnosis, informs precision treatment approaches, and supports the development of disease progression biomarkers - all aligned with U.S. public health and biomedical innovation priorities.
To support her petition under the National Interest Waiver (NIW) category, we highlighted:
● 10 peer-reviewed journal articles and 1 first-authored abstract, with publications in respected journals;
● 79 citations, with multiple papers ranked among the top 10–20% most cited in clinical and biological sciences;
● Research that has received recognition through peer-reviewed funding from major institutions.
● Influential contributions in telomere biology, whole-exome sequencing, RNA profiling, and cancer genomics, widely cited by peers in public health, developmental biology, and genetic research.
Her discoveries have been used to inform studies on pediatric obesity, bronchiectasis, syndromic genetic conditions, and thyroid and breast cancer susceptibility, demonstrating the translational value of her work in improving disease understanding and health outcomes.Her petition was successfully approved after 11 months and 17 days, affirming her demonstrated impact and future potential. We look forward to her continued contributions to the future of genomics-based medicine and chronic disease research.